Sustained reduction in Kawasaki disease during the post-acute phase of the coronavirus disease 2019 pandemic: a follow-up study in Shiga, Japan.

Publication date: Jul 31, 2025

To determine the epidemiologic change in Kawasaki disease during the post-acute phase of the coronavirus disease 2019 pandemic compared with the pre- and acute phases. A follow-up epidemiological study was conducted using data obtained from hospitalised patients with Kawasaki disease in Shiga Prefecture, Japan. The study period was divided into three phases: pre-pandemic (January 2015 to March 2020), acute pandemic (April 2020 to December 2020), and post-acute pandemic (January 2021 to December 2022). The incidence of Kawasaki disease was compared among these phases, focusing on monthly variation, patient age, and regional population density. A total of 1,598 patients with Kawasaki disease were analysed. The per cent change in Kawasaki disease incidence from the pre-pandemic phase was -33. 8% and -27. 9% in the acute and post-acute phases, respectively. Monthly variation during the post-acute phase dramatically differed from that observed in the pre- and acute phases, with the highest incidence in August and the lowest in April. The Kawasaki disease reduction was larger in patients ≥4 years old during the post-acute phase. An association between population density and reduction in Kawasaki disease incidence was no longer observed during the post-acute phase, contrary to the result during the acute phase. The reduction in Kawasaki disease incidence in Shiga Prefecture remained in the post-acute phase of the coronavirus disease 2019 pandemic, although seasonal variation dramatically differed from the traditional pattern. Infection prevention measures by individuals might reduce Kawasaki disease development in the children ≥4 years old.

Concepts Keywords
April coronavirus disease 2019 pandemic
Cardiol Kawasaki disease
Japan
Pandemic

Semantics

Type Source Name
disease MESH Kawasaki disease
disease MESH coronavirus disease 2019
disease MESH Infection
disease MESH infectious disease
pathway REACTOME Infectious disease

Original Article

(Visited 2 times, 1 visits today)